Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Cancer Research

• Publication date

  1998-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9605753
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional role of estrogen metabolism in target cells: review and perspectives.

  1998cited by this paper
• Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators.

  1997cited by this paper
• 2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and Fas expression.

  1997cited by this paper
• Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder.

  1997cited by this paper
• Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States

  1997cited by this paper
• Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder.

  1997cited by this paper
• Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and parkinsonian patients in Finland.

  1997cited by this paper
• Body size and risk of breast cancer.

  1997cited by this paper
• An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.

  1997cited by this paper
• Molecular mechanisms of estrogen carcinogenesis.

  1996cited by this paper
• 2-hydroxyestrone: the 'good' estrogen.

  1996cited by this paper
• Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk.

  1996cited by this paper
• No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity.

  1996cited by this paper
• Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.

  1996cited by this paper
• Molecular Mechanisms of Estrogen Carcinogenesis

  1996influential reference
• Genetic susceptibility to cancer from exogenous and endogenous exposures

  1996cited by this paper
• A Meta‐analysis of Body Mass Index and Risk of Premenopausal Breast Cancer

  1995cited by this paper
• DNA repair related to multiple skin cancers and drug use.

  1994cited by this paper
• Estrogen metabolism and excretion in Oriental and Caucasian women.

  1994cited by this paper
• Catechol-O-methyltransferase-catalyzed rapid O-methylation of mutagenic flavonoids. Metabolic inactivation as a possible reason for their lack of carcinogenicity in vivo.

  1994cited by this paper
• P450 enzymes of estrogen metabolism.

  1993cited by this paper
• Increased catechol estrogen metabolism as a risk factor for nonfamilial breast cancer

  1992cited by this paper
• The role of the regulatory enzymes of catecholamine synthesis in Parkinson's disease

  1992cited by this paper
• Characteristics of catechol O-methyl-transferase (COMT) and properties of selective COMT inhibitors.

  1992cited by this paper
• Nutritional epidemiology of postmenopausal breast cancer in western New York.

  1991cited by this paper
• Genotoxic effects of estrogens.

  1990cited by this paper
• Difference in erythrocyte catechol‐O‐methyltransferase activity between Orientals and Caucasians: Difference in levodopa tolerance

  1984cited by this paper
• Biological action of catechol oestrogens.

  1981cited by this paper
• Catechol-O-methyl transferase: pharmacological aspects and physiological role.

  1975cited by this paper
• Effects of drugs and environmental chemicals on steroid metabolism

  1973cited by this paper

• Exploration of plasma adiponectin, leptin, and COMT genotype on blood pressure among women who are post-menopause

  2023influential citation
• Endogenous estrogens—breast cancer and chemoprevention

  2021cites this paper
• Genetic and Proteinic Linkage of MAO and COMT with Oral Potentially Malignant Disorders and Cancers of the Oral Cavity and Pharynx

  2021cites this paper
• Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial

  2018cites this paper
• Meta-analysis of genetic polymorphisms in xenobiotic metabolizing enzymes and their association with breast cancer risk

  2018cites this paper
• Vasomotor, urogenital, psychological, and somatic symptoms in association with CYP1B1 polymorphisms in Slovak women of different menopausal status

  2018cites this paper
• The Val158Met polymorphism in COMT gene and cancer risk: role of endogenous and exogenous catechols

  2017influential citation
• POLYMORPHISMS OF ESTROGEN BIOSYNTHESIS AND METABOLIZING GENES IN EGYPTIAN WOMEN WITH BREAST CANCER.

  2017cites this paper
• Evaluation of Active Hexose Correlated Compound (AHCC) in Combination With Anticancer Hormones in Orthotopic Breast Cancer Models

  2017cites this paper
• The MAOA, COMT, MTHFR and ESR1 gene polymorphisms are associated with the risk of depression in menopausal women.

  2016cites this paper
• association between the cOMT Val158Met polymorphism and risk of cancer: evidence from 99 case–control studies

  2015cites this paper
• Celecoxib influences steroid sulfonation catalyzed by human recombinant sulfotransferase 2A1.

  2015cites this paper
• Estrogen metabolism and breast cancer.

  2015cites this paper
• Catechol-O-methyltransferase, a new target for pancreatic cancer therapy

  2015cites this paper
• POLIMORFIZM KATECHOLO-O-METYLOTRANSFERAZY (COMT) ORAZ RECEPTORÓW DOPAMINY (DRD1, DRD4) W ETIOLOGII I TERAPII STANU PRZEDRZUCAWKOWEGO

  2014cites this paper
• Comprehensive interrogation of CpG island methylation in the gene encoding COMT, a key estrogen and catecholamine regulator

  2014cites this paper
• Lack of associations of the COMT Val158Met polymorphism with risk of endometrial and ovarian cancer: a pooled analysis of case-control studies.

  2014cites this paper
• A steroid metabolizing gene variant in a polyfactorial model improves risk prediction in a high incidence breast cancer population

  2014cites this paper
• Contribution of catechol-O-methyltransferase Val158Met polymorphism to endometrial cancer risk in postmenopausal women: a meta-analysis.

  2013cites this paper
• Polymorphisms of catechol estrogens metabolism pathway genes and breast cancer risk in Mexican women.

  2013cites this paper
• Conjugation, Transport, and Elimination of Drugs in Humans

  2012cites this paper
• Modulation of steroid sulfonation by small molecules that interact with sulfotransferases and sulfatases

  2012cites this paper
• Association between the COMT Val158Met polymorphism and breast cancer risk: a meta-analysis of 30,199 cases and 38,922 controls

  2012cites this paper
• Increased COMT expression in pancreatic cancer and correlation with clinicopathologic parameters

  2012cites this paper
• Defining the role of echinocandin catechol functional groups in the development of secondary hepatocellular carcinoma.

  2012cites this paper
• Distribution, regulation and physiological roles of catechol-O-methyltransferase (COMT) in rodents

  2012cites this paper
• Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis

  2012cites this paper
• Catechol-O-methyltransferase: characteristics, polymorphisms and role in breast cancer.

  2012cites this paper
• Melding breast and prostate cancers alter egos

  2011cites this paper
• Catechol-O-methyltransferase Val 108/158 Met polymorphism and breast cancer risk: a case control study in Syria

  2011cites this paper
• Estrogen pathway polymorphisms and mammographic density.

  2011cites this paper
• Towards non-surgical therapy for uterine fibroids: catechol-O-methyl transferase inhibitor shrinks uterine fibroid lesions in the Eker rat model.

  2011cites this paper
• Proteomic Analysis of MCF-7 Breast Cancer Cell Line Exposed To Leptin

  2011cites this paper
• Polymorphisms of COMT and XPD and risk of esophageal squamous cell carcinoma in a population of Yili Prefecture, in Xinjiang, China

  2011cites this paper
• Inhibition of catechol-O-methyltransferase activity in human breast cancer cells enhances the biological effect of the green tea polyphenol (-)-EGCG

  2010cites this paper
• Novel pathway analysis of genomic polymorphism-cancer risk interaction in the Breast Cancer Prevention Trial.

  2010cites this paper
• Polymorphic catechol methyltransferase gene , soy isoflavone intake and breast cancer in postmenopausal women : a case control study

  2010cites this paper
• Microsoft Word-18206498-file00

  2010cites this paper
• Environmental Chemicals and Breast Cancer Risk-Why Is There Concern?

  2010cites this paper
• Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls

  2010cites this paper
• Polymorphisms in genes involved in the estrogen pathway and mammographic density

  2010cites this paper
• COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case–control studies

  2010cites this paper
• Urinary polyphenols and breast cancer risk: results from the Shanghai Women’s Health Study

  2010cites this paper
• Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response

  2010cites this paper
• Possible Risk Modification by Polymorphisms of Estrogen Metabolizing Genes in Familial Breast Cancer Susceptibility in an Indian Population

  2010cites this paper
• O-Methylation of Catechol Estrogens by Human Placental Catechol-O-Methyltransferase: Interindividual Differences in Sensitivity to Heat Inactivation and to Inhibition by Dietary Polyphenols

  2010cites this paper
• Low Enzymatic Activity Haplotypes of the Human Catechol-O-Methyltransferase Gene: Enrichment for Marker SNPs

  2009cites this paper
• A prospective study of genetic polymorphism in MPO, antioxidant status, and breast cancer risk

  2009cites this paper
• Risk factors for breast cancer in East Asian women relative to women in the West

  2009cites this paper
• Reduced COMT activity as a possible environmental risk factor for breast cancer. Opinion

  2009cites this paper
• Maternal Dioxin Exposure Combined with a Diet High in Fat Increases Mammary Cancer Incidence in Mice

  2009cites this paper
• Inhibition of human catechol-O-methyltransferase (COMT)-mediated O-methylation of catechol estrogens by major polyphenolic components present in coffee.

  2009cites this paper
• CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study

  2009cites this paper
• Catechol O-methyltransferase pharmacogenomics: human liver genotype–phenotype correlation and proximal promoter studies

  2009cites this paper
• The Role of 17beta-Estradiol on 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated Oxidative DNA Damage in Liver Cell Models

  2009cites this paper
• COMT Genotype, sex steroids, and bone phenotype in mice and men

  2009cites this paper
• Genetic Polymorphisms in the Catechol Estrogen Metabolism Pathway and Breast Cancer Risk

  2009cites this paper
• Identification of a novel haplotype of the human catechol-O-methyltransferase gene.

  2009cites this paper
• Cyclins in Breast Cancer

  2008cites this paper
• Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk

  2008cites this paper
• Large-Scale Evaluation of Genetic Variants in Candidate Genes for Colorectal Cancer Risk in the Nurses' Health Study and the Health Professionals' Follow-up Study

  2008cites this paper
• Estrogenic phenol and catechol metabolites of PCBs modulate catechol-O-methyltransferase expression via the estrogen receptor: potential contribution to cancer risk.

  2008cites this paper
• Faits et arguments Perturbateurs endocriniens environnementaux et cancer du sein : de nouveaux facteurs de risque ? Breast risk cancer and environmental endocrine disruptors

  2008cites this paper
• Catechol-O-methyltransferase: effects of the val108met polymorphism on protein turnover in human cells.

  2008cites this paper
• Characterization of a novel human catechol-O-methyl-transferase mutant with triplet point mutations.

  2008cites this paper
• On the sulfation and methylation of catecholestrogens in human mammary epithelial cells and breast cancer cells.

  2008cites this paper
• Genetic polymorphisms, the metabolism of estrogens and breast cancer: a review.

  2008cites this paper
• COMT GENOTYPE , SEX STEROIDS AND BONE PHENOTYPE IN MAN AND MICE

  2008cites this paper
• Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms.

  2008cites this paper
• Influence of diet and maternal dioxin on endocrine disruption: Puberty, metabolic syndrome, and breast cancer

  2008cites this paper
• [Environmental endocrine disruptors and breast cancer: new risk factors?].

  2008cites this paper
• Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition.

  2007cites this paper
• Functional polymorphism of thymidylate synthase, but not of the COMT and IL‐1B genes, is associated with breast cancer

  2007cites this paper
• A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives

  2007influential citation
• Val153Met Polymorphism of Catechol-O-Methyltransferase and Prevalence of Uterine Leiomyomata

  2007cites this paper
• CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients

  2007cites this paper
• THE ROLE OF CATECHOL-O-METHYLTRANSFERASE (COMT) AND THE EFFECTS OF COMT INHIBITION IN BRAIN AND IN CARDIOVASCULAR AND RENAL PATHOPHYSIOLOGY

  2007cites this paper
• Genetic Predisposition to Breast and Ovarian Cancer in Eastern Finnish

  2007cites this paper
• Age‐specific association of steroid hormone pathway gene polymorphisms with breast cancer risk

  2007cites this paper
• The Val158Met polymorphism of the catechol‐O‐methyltransferase gene is not associated with the risk of sporadic or latent prostate cancer in Japanese men

  2007cites this paper
• Cancer genetics of epigenetic genes.

  2007cites this paper
• Cytochrome P450 17A1 and Catechol O-Methyltransferase Polymorphisms and Age at Lynch Syndrome Colon Cancer Onset in Newfoundland

  2007cites this paper
• Detection of catechol-O-methyltransferase Val158Met polymorphism by a simple one-step tetra-primer amplification refractory mutation system-PCR.

  2007cites this paper
• Breast cancer: a candidate gene approach across the estrogen metabolic pathway

  2007cites this paper
• Lipid peroxidation, oxidative stress genes and dietary factors in breast cancer protection: a hypothesis

  2007cites this paper
• Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence.

  2007cites this paper
• Multilocus Genotypes Spanning Estrogen Metabolism Associated with Breast Cancer and Fibroadenoma

  2006cites this paper
• Pharmacogenomics: Catechol O-Methyltransferase to Thiopurine S-Methyltransferase

  2006influential citation
• Case–control study of risk factors for breast cancer in Nigerian women

  2006cites this paper
• Chapter 1 Bioactivation of Estrogens to Toxic Quinones

  2006cites this paper
• Catechol-O-methyltransferase haplotypes and breast cancer among women on Long Island, New York

  2006cites this paper
• Functional maternal catechol-O-methyltransferase polymorphism and fetal growth restriction

  2006cites this paper
• Functional maternal catechol-O-methyltransferase polymorphism and fetal growth restriction.

  2006cites this paper
• Departure from multiplicative interaction for catechol-O-methyltransferase genotype and active/passive exposure to tobacco smoke among women with breast cancer

  2006cites this paper
• Xénoestrogènes et cancer du sein : de nouveaux facteurs de risque accessibles à la prévention ?

  2006cites this paper
• Estrogen metabolism and breast cancer risk--a review.

  2006cites this paper
• Association of the COMT Gene Polymorphism with the Risk of PCOS in Korean Women

  2006cites this paper
• Cytochrome P450 1B1 and Catechol-O-Methyltransferase Genetic Polymorphisms and Breast Cancer Risk in Chinese Women: Results from the Shanghai Breast Cancer Study and a Meta-analysis

  2005cites this paper
• ESTROGENS, GENETIC POLYMORPHISMS AND BREAST CANCER RISK IN NIGERIAN WOMEN

  2005cites this paper
• Genetic Plymorphisms, Estrogens, and Breast Density

  2005cites this paper